Arca
Skip to content
Tools
Tools

Sovereign Mini

Laparoscope, General & Plastic Surgery. 510(k) K123102, from Aesculap, Inc. (Center Valley, PA). Product code GCJ, class 2.

As of Nov 18, 2026, K123102 is an FDA 510(k) held by Aesculap, Inc., substantially equivalent on Jan 3, 2013 after 93 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jan 3, 2013
  • Review time: 93 days
  • Recalls: 0
  • Cited as a predicate by: 3 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

Aesculap's Sovereign® mini system is indicated for use in adult and pediatric diagnostic and therapeutic general endoscopy and laparoscopy surgery. *5* *K123102* *Page 2 of 2*

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

3 later 510(k) summaries name this device as a predicate

Other GCJ Clearances

The newest 510(k)s for the same product code; their median review was 128 days; see every GCJ device

Record

Type
Special
Received
Oct 2, 2012
Review panel
Gastroenterology, Urology
Regulation
21 CFR 876.1500

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.